Aminophyllin and Terbutaline sulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aminophyllin (aminophylline) and Terbutaline sulfate (terbutaline sulfate). Common drug interactions include dry skin among females and angina pectoris among males.

The phase IV clinical study analyzes what interactions people have when they take Aminophyllin and Terbutaline sulfate. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Aminophyllin?

Aminophyllin has active ingredients of aminophylline. eHealthMe is studying from 3,118 Aminophyllin users. Check the latest studies of Aminophyllin.

What is Terbutaline sulfate?

Terbutaline sulfate has active ingredients of terbutaline sulfate. It is often used in asthma. eHealthMe is studying from 2,777 Terbutaline sulfate users. Check the latest studies of Terbutaline sulfate.



On Jul, 10, 2026

56 people who take Aminophyllin and Terbutaline sulfate together, and have interactions are studied.

Aminophyllin and Terbutaline sulfate drug interactions.

What are the common drug interactions of Aminophyllin and Terbutaline Sulfate, by gender? *:

female:

  1. Dry skin
  2. Gamma-glutamyltransferase increased
  3. Gasping (laboured breathing)
  4. Intestinal perforation (complete penetration of the wall of the intestine)
  5. Mucous membrane disorder (disease of mucous membrane)
  6. Occult blood positive
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Po2 increased
  10. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

male:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Ventricular fibrillation (abnormally irregular heart rhythm)
  3. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  4. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  5. Craniosynostosis (a baby is born with an abnormally shaped skull or develops one during growth)
  6. Dyspnoea (difficult or laboured respiration)
  7. Haemostasis (stopping of bleeding)
  8. Liver disorder (liver diseases)
  9. Mydriasis (a dilation of the pupil)
  10. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)

What are the common drug interactions of Aminophyllin and Terbutaline Sulfate, by age (0-1 to 60+)? *:

0-1:

  1. Craniosynostosis (a baby is born with an abnormally shaped skull or develops one during growth)

2-9:

  1. Accelerated idioventricular rhythm (rate of cardiac contraction)
  2. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  3. Drug ineffective

10-19:

  1. Drug ineffective

20-29:

  1. Hyperlactacidaemia (the acidosis and also reduces the capacity of the kidney)
  2. Abdominal pain
  3. Lactic acidosis (low ph in body tissues)
  4. Abdominal rigidity
  5. Anaphylactic reaction (serious allergic reaction)
  6. Blood ph increased
  7. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Po2 increased
  10. Respiratory distress (difficulty in breathing)

30-39:

n/a

40-49:

  1. Drug ineffective
  2. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  3. Appendicitis (inflammation of the appendix)
  4. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  5. Circulatory collapse
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Cor pulmonale (enlargement of the right ventricle of the heart)
  8. Dyspnoea (difficult or laboured respiration)
  9. Intestinal perforation (complete penetration of the wall of the intestine)
  10. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

50-59:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood alkaline phosphatase increased
  4. Blood creatinine increased
  5. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  6. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  7. Gamma-glutamyltransferase increased
  8. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

60+:

  1. Colitis (inflammation of colon)
  2. Ventricular fibrillation (abnormally irregular heart rhythm)
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Blood pressure decreased
  6. Cerebral atrophy (decrement in size of brain)
  7. Circulatory collapse
  8. Coma (state of unconsciousness lasting more than six hours)
  9. Coronary artery atherosclerosis (life-threatening blockages in the arteries of your heart)
  10. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 19.64%
  2. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 10 people, 17.86%
  3. High Blood Pressure: 8 people, 14.29%
  4. Acute Severe Asthma: 7 people, 12.50%
  5. Sedation: 3 people, 5.36%
  6. Pneumonia: 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Aminophyllin and Terbutaline sulfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aminophyllin and Terbutaline sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aminophyllin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Terbutaline sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aminophyllin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Terbutaline sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aminophylline and terbutaline sulfate (the active ingredients of Aminophyllin and Terbutaline sulfate, respectively), and Aminophyllin and Terbutaline sulfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: